Spots Global Cancer Trial Database for stage iia prostate cancer
Every month we try and update this database with for stage iia prostate cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer | NCT01220973 | Prostate Cancer | atorvastatin ca... celecoxib laboratory biom... | 18 Years - 120 Years | Rutgers, The State University of New Jersey | |
| Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer | NCT00032006 | Prostate Cancer | brachytherapy radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer | NCT03103321 | Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage III Prost... Stage I Prostat... PSA Level Five ... PSA Level Less ... PSA Level Ten t... | Internet-Based ... Internet-Based ... Best Practice Quality-of-Life... Questionnaire A... Survey Administ... Laboratory Biom... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer | NCT00601406 | Breast Cancer Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Primary Periton... Prostate Cancer Sarcoma Vaginal Cancer Vulvar Cancer | gene expression... gene rearrangem... polymorphism an... laboratory biom... radiation thera... | - | National Cancer Institute (NCI) | |
| Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer Patients | NCT01882985 | Adenocarcinoma ... Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... | Docetaxel Lycopene | 21 Years - | University of California, Irvine | |
| Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer | NCT00423475 | Prostate Cancer | goserelin aceta... adjuvant therap... radiation thera... | 18 Years - 120 Years | UNICANCER | |
| Tangerine or Red Tomato Juice in Treating Patients With Prostate Cancer Undergoing Surgery | NCT02144649 | Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... Stage IV Prosta... | dietary interve... dietary interve... questionnaire a... Correlative stu... | 21 Years - | Ohio State University Comprehensive Cancer Center | |
| PSA Antibody Levels in Samples From Patients With Prostate Cancer Treated on Protocol ECOG-E9802 | NCT01672905 | Prostate Cancer | laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence | NCT00003858 | Prostate Cancer | mitoxantrone hy... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer | NCT00020995 | Prostate Cancer | therapeutic die... | 40 Years - 80 Years | National Cancer Institute (NCI) | |
| Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer | NCT00551525 | Prostate Cancer | Radiotherapy Samarium 153 | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing Surgery | NCT01912820 | Adenocarcinoma ... Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... Stage IV Prosta... | green tea extra... quercetin placebo therapeutic con... laboratory biom... | 40 Years - 75 Years | Jonsson Comprehensive Cancer Center | |
| Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer | NCT01546987 | Prostate Cancer | GnRH agonist Anti-androgen TAK-700 Radiation thera... | 18 Years - | Radiation Therapy Oncology Group | |
| Radiation Therapy in Treating Patients With Prostate Cancer | NCT01434290 | Prostate Cancer Psychosocial Ef... Radiation Toxic... Sexual Dysfunct... | 36.25 Gy IMRT 51.6 Gy IMRT | 18 Years - | Radiation Therapy Oncology Group | |
| Helping African American Prostate Cancer Survivors and Their Partners Cope With Challenges After Surgery for Prostate Cancer | NCT00869739 | Cancer Survivor Depression Gastrointestina... Male Erectile D... Prostate Cancer Psychosocial Ef... Urinary Complic... | telephone-based... educational int... partner-assiste... questionnaire a... psychosocial as... quality-of-life... | - | East Carolina University | |
| Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancer | NCT00670046 | Prostate Cancer | valproic acid standard of car... | 18 Years - 85 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer | NCT00767286 | Prostate Cancer | flutamide goserelin aceta... low-LET cobalt-... low-LET photon ... | 50 Years - | National Cancer Institute (NCI) | |
| Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone, Bicalutamide Alone, and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical Prostatectomy | NCT00086736 | Prostate Cancer | bicalutamide eflornithine oral eflornithi... oral bicalutami... | 18 Years - | University of Alabama at Birmingham | |
| Changes in DNA After Radiation Therapy in Patients With Prostate Cancer | NCT00899912 | Prostate Cancer | microarray anal... diagnostic labo... | 18 Years - | Radiation Therapy Oncology Group | |
| Positron Emission Tomography in Prostate Cancer | NCT00121212 | Prostate Cancer | carbon-11 aceta... | - | Washington University School of Medicine | |
| Computer Planned Radiation Therapy in Treating Patients With Prostate Cancer | NCT00003104 | Prostate Cancer | radiation thera... | - | Memorial Sloan Kettering Cancer Center | |
| Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Diagnosing the Extent of Disease in Patients With Prostate Cancer | NCT00032058 | Prostate Cancer | magnetic resona... magnetic resona... | 18 Years - | National Cancer Institute (NCI) | |
| Lycopene or Omega-3 Fatty Acid Nutritional Supplements in Treating Patients With Stage I or Stage II Prostate Cancer | NCT00402285 | Prostate Cancer | lycopene supple... fish oil supple... Placebo | - | University of California, San Francisco | |
| Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors | NCT03880422 | Cancer Survivor Obesity Overweight Prostate Adenoc... Stage A Prostat... Stage B Prostat... Stage C Prostat... Stage D Prostat... Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Dietary Interve... Educational Int... Exercise Interv... Quality-of-Life... Survey Administ... | 18 Years - | Roswell Park Cancer Institute | |
| Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer | NCT00547339 | Prostate Cancer | stereotactic bo... stereotactic bo... stereotactic bo... stereotactic bo... | 18 Years - 120 Years | University of Texas Southwestern Medical Center | |
| Radiation Therapy in Treating Patients With Prostate Cancer | NCT00002480 | Prostate Cancer | radiation thera... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| High-Intensity Focused Ultrasound in Treating Patients With Locally Recurrent Prostate Cancer | NCT00030277 | Prostate Cancer | high-intensity ... | 40 Years - 80 Years | National Cancer Institute (NCI) | |
| Ultrasound in Treating Patients With Prostate Cancer Confined to the Prostate | NCT00030290 | Prostate Cancer | high-intensity ... | 40 Years - 80 Years | National Cancer Institute (NCI) | |
| Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate Cancer | NCT00345813 | Prostate Cancer | soy isoflavones soy protein iso... placebo | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel | NCT01469338 | Diarrhea Hormone-resista... Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... Stage IV Prosta... | cabazitaxel prednisone octreotide pamo... questionnaire a... octreotide acet... | 18 Years - | University of Southern California | |
| Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone, Bicalutamide Alone, and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical Prostatectomy | NCT00086736 | Prostate Cancer | bicalutamide eflornithine oral eflornithi... oral bicalutami... | 18 Years - | University of Alabama at Birmingham | |
| Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer | NCT00849082 | Prostate Cancer | cyproterone ace... goserelin aceta... radiation thera... | - 79 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer | NCT00288080 | Prostate Cancer | Dexamethasone Prednisone docetaxel Oral antiandrog... Radiation thera... LHRH agonist | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| Technetium Tc 99m Demobesin-4 for Imaging Procedures in Patients With Prostate Cancer | NCT00989105 | Prostate Cancer | immunohistochem... laboratory biom... pharmacological... computed tomogr... magnetic resona... single photon e... technetium Tc 9... | 18 Years - | Cancer Research UK | |
| PSA Antibody Levels in Samples From Patients With Prostate Cancer Treated on Protocol ECOG-E9802 | NCT01672905 | Prostate Cancer | laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| APC8015 and Bevacizumab in Treating Patients With Prostate Cancer | NCT00027599 | Prostate Cancer | bevacizumab prostatic acid ... sipuleucel-T therapeutic aut... in vitro-treate... | - | National Cancer Institute (NCI) | |
| Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer | NCT00376792 | Prostate Cancer | docetaxel active surveill... adjuvant therap... | 18 Years - 70 Years | National Cancer Institute (NCI) | |
| Low-Fat Diet and/or Flaxseed in Preventing Prostate Cancer | NCT00049309 | Prostate Cancer | dietary interve... flaxseed | 18 Years - 120 Years | Duke University | |
| Comparison of Radiation Therapy Regimens in Treating Patients With Localized Prostate Cancer | NCT00010244 | Prostate Cancer | radiation thera... | 0 Years - 74 Years | UNICANCER | |
| Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy | NCT01656304 | Adenocarcinoma ... Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... | bevacizumab laboratory biom... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Green Tea Extract in Treating Patients With Low-Risk Prostate Cancer | NCT01928485 | Stage I Prostat... Stage IIA Prost... Stage IIB Prost... | active surveill... Sunphenon laboratory biom... Questionnaire A... | 45 Years - 85 Years | Case Comprehensive Cancer Center | |
| Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence | NCT00003858 | Prostate Cancer | mitoxantrone hy... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Effects of Tomato-Soy Juice on Biomarkers in Patients With Prostate Cancer Undergoing Prostatectomy | NCT01009736 | Prostate Cancer | tomato-soy juic... laboratory biom... pharmacological... therapeutic con... | - | Ohio State University Comprehensive Cancer Center | |
| EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma | NCT00004261 | Breast Cancer Cervical Cancer Head and Neck C... Prostate Cancer Sarcoma | EF5 flow cytometry fluorescent ant... immunohistochem... biopsy | 18 Years - 120 Years | University Health Network, Toronto | |
| Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy | NCT01656304 | Adenocarcinoma ... Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... | bevacizumab laboratory biom... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors | NCT00433407 | Breast Cancer Lung Cancer Ovarian Cancer Prostate Cancer Sarcoma Unspecified Adu... | trastuzumab | - | Jonsson Comprehensive Cancer Center | |
| SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer | NCT00026377 | Prostate Cancer | bicalutamide flutamide goserelin aceta... leuprolide acet... SU5416 radiation thera... | - | University of Chicago | |
| Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors | NCT03880422 | Cancer Survivor Obesity Overweight Prostate Adenoc... Stage A Prostat... Stage B Prostat... Stage C Prostat... Stage D Prostat... Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Dietary Interve... Educational Int... Exercise Interv... Quality-of-Life... Survey Administ... | 18 Years - | Roswell Park Cancer Institute | |
| Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer | NCT00967954 | Prostate Cancer | antiandrogen th... releasing hormo... DNA analysis RNA analysis comparative gen... gene expression... laboratory biom... diffusion-weigh... magnetic resona... | - | National Cancer Institute (NCI) | |
| Study of a Polymorphism in Patients With Prostate Cancer | NCT00900185 | Prostate Cancer | mutation analys... polymerase chai... polymorphism an... | - | National Cancer Institute (NCI) | |
| Diffuse Optical Imaging With Indocyanine Green Solution in Imaging Pelvic Lymph Nodes in Patients With Stage II Prostate Cancer Undergoing Surgery | NCT02119858 | Stage IIA Prost... Stage IIB Prost... | indocyanine gre... diffuse optical... robot-assisted ... therapeutic lym... | 18 Years - 80 Years | City of Hope Medical Center | |
| Vigorous or Moderate Exercise in Enhancing Active Surveillance in Patients With Localized Prostate Cancer | NCT02179762 | Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... | moderate exerci... vigorous exerci... questionnaire a... laboratory biom... vigorous exerci... Exercise Logs Adherence Exercise and bo... | 18 Years - 75 Years | Case Comprehensive Cancer Center | |
| Atorvastatin Calcium in Preventing Metabolic Syndrome in Prostate Cancer Patients Receiving Androgen-Deprivation Therapy | NCT01555632 | Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... Stage IV Prosta... | atorvastatin ca... placebo | 19 Years - | University of Nebraska | |
| GM-CSF Before Surgery in Treating Patients With Localized Prostate Cancer | NCT00305669 | Prostate Cancer | sargramostim immunohistochem... immunological d... laboratory biom... conventional su... neoadjuvant the... | - | University of California, San Francisco | |
| Lapatinib Ditosylate in Treating Patients With a Rising PSA Indicating Recurrent Prostate Cancer | NCT00103194 | Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... | lapatinib ditos... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Group Therapy Compared With Educational Materials in Patients With Prostate Cancer | NCT00002848 | Prostate Cancer Psychosocial Ef... | psychosocial as... quality-of-life... | - | University of Rochester | |
| Brachytherapy in Treating Patients With Recurrent Prostate Cancer | NCT00005939 | Prostate Cancer | brachytherapy phosphorus P32 | 21 Years - | National Cancer Institute (NCI) | |
| Internal Radiation Therapy in Treating Patients With Low-Risk Prostate Cancer | NCT01859689 | Adenocarcinoma ... Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... | brachytherapy image-guided ra... laboratory biom... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No Symptoms | NCT00005073 | Prostate Cancer | zoledronic acid | 18 Years - | Novartis | |
| Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer | NCT00043069 | Osteoporosis Prostate Cancer | calcium carbona... cholecalciferol Estrogen Antago... risedronate sod... placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer | NCT00057759 | Prostate Cancer Psychosocial Ef... Radiation Toxic... Sexual Dysfunct... Sexuality and R... | sildenafil citr... Placebo | 18 Years - | Radiation Therapy Oncology Group | |
| Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing Surgery | NCT01912820 | Adenocarcinoma ... Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... Stage IV Prosta... | green tea extra... quercetin placebo therapeutic con... laboratory biom... | 40 Years - 75 Years | Jonsson Comprehensive Cancer Center | |
| Studying Repeated DCE-MRI and DWI in Patients Diagnosed With Prostate Cancer | NCT01562223 | Prostate Cancer | motexafin gadol... | 18 Years - | American College of Radiology Imaging Network | |
| Atrasentan in Treating Patients With Prostate Cancer | NCT00046943 | Prostate Cancer | atrasentan hydr... | 19 Years - | National Cancer Institute (NCI) | |
| High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer | NCT01655836 | Prostate Cancer Adenocarcinoma ... Recurrent Prost... Stage IIA Prost... Stage IIB Prost... | Brachytherapy Stereotactic Bo... Quality-of-life... Questionnaire a... | 18 Years - | Thomas Jefferson University | |
| Comparison of Radiation Therapy Regimens in Treating Patients With Localized Prostate Cancer | NCT00010244 | Prostate Cancer | radiation thera... | 0 Years - 74 Years | UNICANCER | |
| Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking | NCT01535040 | Breast Cancer Colorectal Canc... Lung Cancer Prostate Cancer Tobacco Use Dis... | memantine hydro... placebo | 18 Years - | Wake Forest University Health Sciences | |
| Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance | NCT01238172 | Prostate Cancer | dietary educati... prostate cancer... | 50 Years - 80 Years | Alliance for Clinical Trials in Oncology | |
| Intensity-Modulated Radiation Therapy in Treating Patients With Prostate Cancer | NCT00946543 | Prostate Cancer | hypofractionate... intensity-modul... | - | National Cancer Institute (NCI) | |
| External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer | NCT00006365 | Prostate Cancer | brachytherapy iodine I 125 radiation thera... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| PSA Levels and Biopsy Samples After Implant Radiation and Hormone Therapy in Patients With Stage I or Stage II Prostate Cancer | NCT00898326 | Prostate Cancer | biopsy | 20 Years - 75 Years | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | |
| Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer | NCT00589472 | Prostate Adenoc... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... | Bicalutamide Goserelin Aceta... Laboratory Biom... Leuprolide Acet... Therapeutic Con... Vorinostat | 19 Years - | National Cancer Institute (NCI) | |
| Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer | NCT02176902 | Adenocarcinoma ... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... | behavioral diet... behavioral diet... omega-3 fatty a... laboratory biom... | 50 Years - 80 Years | Jonsson Comprehensive Cancer Center | |
| Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy | NCT00002874 | Prostate Cancer | bicalutamide radiation thera... placebo | - | Radiation Therapy Oncology Group | |
| MRI in Diagnosing Prostate Cancer | NCT01292291 | Prostate Cancer | biologic sample... laboratory biom... study of socioe... diffusion-weigh... dynamic contras... multiparametric... quality-of-life... transperineal p... transrectal pro... ultrasound-guid... | - | National Cancer Institute (NCI) | |
| Lapatinib Ditosylate in Treating Patients With a Rising PSA Indicating Recurrent Prostate Cancer | NCT00103194 | Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... | lapatinib ditos... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer | NCT00601406 | Breast Cancer Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Primary Periton... Prostate Cancer Sarcoma Vaginal Cancer Vulvar Cancer | gene expression... gene rearrangem... polymorphism an... laboratory biom... radiation thera... | - | National Cancer Institute (NCI) | |
| Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer | NCT00005044 | Prostate Cancer | Casodex Eulexin LHRH agonist radiation thera... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| Study of Blood and Urine Samples in Patients With Newly Diagnosed Localized Prostate Cancer Treated With Hormone Therapy and Radiation Therapy. ICORG 06-15 | NCT00955435 | Prostate Cancer | Non-interventio... Protein express... Proteomic profi... Laboratory biom... | 18 Years - | Cancer Trials Ireland | |
| Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer | NCT00767286 | Prostate Cancer | flutamide goserelin aceta... low-LET cobalt-... low-LET photon ... | 50 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
